Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 14Terminated 3Withdrawn 2Unknown 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 2CNS 1

Conditions

cyclopia sequence 3Head and Neck Neoplasms 2Laryngeal Diseases 1Carcinoma 1Brain Neoplasms 1

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Minocycline × Clear all
NCT02055963 2022-10-20

Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer

M.D. Anderson Cancer Center

Phase 2 Terminated
30 enrolled 9 charts
Head & Neck

cyclopia sequence, Head and Neck Neoplasms

NCT02201563 2018-06-25

Minocycline Therapy for Management of Adverse Radiation Effects

University of Pittsburgh

Phase 1 Terminated
1 enrolled
CNS

cyclopia sequence, Brain Neoplasms

NCT01219673 2015-02-10

Symptom Burden in Head and Neck Cancer

M.D. Anderson Cancer Center

Phase 1/2 Terminated
1 enrolled 2 charts
Head & Neck

cyclopia sequence, Carcinoma, Head and Neck Neoplasms, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡